~~<i id='39A58847B5'><strike id='39A58847B5'><tt id='39A58847B5'><pre id='39A58847B5'></pre></tt></strike></i>~~

Home» knowledge» explore

explore

author：entertainment 2025-10-01 01:54:19 Page View：19142

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： PBMs are inflating the cost of generic drugs. They must be reined in
Next article： Heart attack and stroke risk calculators need revising

explore

Medical leaders decry Supreme Court decision on affirmative action

STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

Election results set back Medicaid expansion plans

KentuckyGovernor-electMattBevincampaignedagainstMedicaidexpansion,buthastakenasofterlineinrecentweek

In Memoriam: Notable people who died in 2023

1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

Kellogg’s is going to war over Mexico’s nutrition label rules

AlexHogan/STATMEXICOCITY—Kellogg’siswagingawarhereoverTigreToñoandSamelTucán.A2019policyrequirescomp